Skip to main content
NVDA$221.56▲1.3%GOOGL$388.47▲0.3%GOOG$384.70▲0.0%AAPL$301.72▲1.1%MSFT$420.04▲0.9%AMZN$264.98▲2.2%TSM$401.17▲2.3%AVGO$417.76▲1.6%TSLA$415.81▲3.3%META$604.49▲0.4%BRK.A$720,840.00▲0.0%BRK.B$480.90▲0.1%WMT$131.27▼2.5%LLY$1,017.68▼0.3%MU$727.57▲4.8%NVDA$221.56▲1.3%GOOGL$388.47▲0.3%GOOG$384.70▲0.0%AAPL$301.72▲1.1%MSFT$420.04▲0.9%AMZN$264.98▲2.2%TSM$401.17▲2.3%AVGO$417.76▲1.6%TSLA$415.81▲3.3%META$604.49▲0.4%BRK.A$720,840.00▲0.0%BRK.B$480.90▲0.1%WMT$131.27▼2.5%LLY$1,017.68▼0.3%MU$727.57▲4.8%

About ImmunityBio, Inc. (IBRX)

ImmunityBio, Inc. (IBRX) is a publicly traded company in the Healthcare sector, specifically in the Biotechnology industry. View real-time stock data, AI analysis, options flow, and convergence signals for IBRX on iGotFomo.

IBRX Key Statistics

0
IBRX key financial statistics
Current Price$8.05Market Cap$8.8 billion
Daily Change+3.74%Volume12.1M
52-Week High$12.4352-Week Low$1.95
SectorHealthcareIndustryBiotechnology

Frequently Asked Questions About IBRX

What is ImmunityBio, Inc. (IBRX)?
ImmunityBio, Inc. (IBRX) is a publicly traded company in the Healthcare sector, operating in the Biotechnology industry.
What is the current IBRX stock price?
As of the latest trading session, IBRX trades at $8.05 per share, with a daily change of +3.74%.
What is IBRX's market capitalization?
ImmunityBio, Inc. has a market capitalization of $8.8 billion, making it a mid-cap stock.
What sector does IBRX belong to?
ImmunityBio, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry. View all Healthcare stocks.